Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NYSE:LDR NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$172.69-0.7%$176.42$136.99▼$182.38$19.28B0.49991,397 shs1.08 million shsDVADaVita$143.83+0.7%$140.10$131.76▼$179.60$10.86B1.11808,807 shs826,679 shsLDRLandauer$67.20$0.00$41.00▼$68.50N/AN/A56,169 shsN/ALHLabcorp$257.68-0.1%$252.66$198.96▼$265.72$21.57B0.82641,740 shs654,647 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics-2.83%-3.20%-0.40%+8.59%+23.73%DVADaVita+0.11%+0.22%+3.45%-0.64%+4.59%LDRLandauer0.00%0.00%0.00%0.00%0.00%LHLabcorp-1.57%-1.76%+1.52%+18.61%+26.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.9494 of 5 stars2.34.04.24.73.42.52.5DVADaVita4.27 of 5 stars2.01.00.04.52.41.73.8LDRLandauerN/AN/AN/AN/AN/AN/AN/AN/ALHLabcorp4.4554 of 5 stars2.42.02.54.23.52.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.69Moderate Buy$185.737.55% UpsideDVADaVita 2.00Hold$164.5014.37% UpsideLDRLandauer 0.00N/AN/AN/ALHLabcorp 2.79Moderate Buy$276.087.14% UpsideCurrent Analyst Ratings BreakdownLatest LDR, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.004/30/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.004/30/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$253.00 ➝ $267.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B1.95$13.18 per share13.10$61.38 per share2.81DVADaVita$12.82B0.85$19.31 per share7.45$4.83 per share29.78LDRLandauerN/AN/AN/AN/AN/AN/ALHLabcorp$13.01B1.66$22.04 per share11.69$96.27 per share2.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$7.9121.8316.462.478.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0914.2511.320.986.63%176.11%4.66%8/5/2025 (Estimated)LDRLandauerN/AN/A0.00∞N/AN/AN/AN/AN/ALHLabcorp$746M$8.6529.7914.691.665.55%15.27%6.97%7/24/2025 (Estimated)Latest LDR, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70N/AN/AN/A$3.36 billionN/A7/24/2025Q2 2025LHLabcorp$4.12N/AN/AN/A$3.49 billionN/A7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.85%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALDRLandauer$1.101.64%N/AN/AN/ALHLabcorp$2.881.12%N/A33.29%N/ALatest LDR, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20254/10/2025LHLabcorpquarterly$0.721.25%5/29/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LDRLandauerN/AN/AN/ALHLabcorp0.681.841.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LDRLandauer79.56%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%LDRLandauer6.60%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLDRLandauerN/AN/AN/ANot OptionableLHLabcorp70,00083.70 million83.00 millionOptionableLDR, LH, DGX, and DVA HeadlinesRecent News About These CompaniesHourglass Capital LLC Acquires Shares of 1,000 Labcorp Holdings Inc. (NYSE:LH)July 8 at 7:56 AM | marketbeat.comHighview Capital Management LLC DE Makes New Investment in Labcorp Holdings Inc. (NYSE:LH)July 8 at 7:09 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Sold by Financial Counselors Inc.July 8 at 6:22 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 8 at 2:29 AM | americanbankingnews.comLabcorp Holdings Inc. (NYSE:LH) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJuly 8 at 2:27 AM | marketbeat.comWhat Makes Labcorp (LH) a New Buy StockJuly 7 at 1:01 PM | zacks.comBank of New York Mellon Corp Sells 11,260 Shares of Labcorp Holdings Inc. (NYSE:LH)July 7 at 5:42 AM | marketbeat.comIFM Investors Pty Ltd Acquires 1,164 Shares of Labcorp Holdings Inc. (NYSE:LH)July 7 at 5:05 AM | marketbeat.comVontobel Holding Ltd. Sells 2,177 Shares of Labcorp Holdings Inc. (NYSE:LH)July 7 at 3:59 AM | marketbeat.comTeacher Retirement System of Texas Purchases 16,318 Shares of Labcorp Holdings Inc. (NYSE:LH)July 5 at 5:22 AM | marketbeat.comLabcorp Hldgs Stock Guidance | NYSE:LH - BenzingaJuly 5 at 2:07 AM | benzinga.com2 S&P 500 Stocks with Promising Prospects and 1 to QuestionJuly 4, 2025 | finance.yahoo.comLeeward Investments LLC MA Has $12.74 Million Stock Position in Labcorp Holdings Inc. (NYSE:LH)July 4, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Purchases 1,108 Shares of Labcorp Holdings Inc. (NYSE:LH)July 4, 2025 | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Director Sells $132,500.00 in StockJuly 3, 2025 | insidertrades.comNew York State Teachers Retirement System Sells 4,410 Shares of Labcorp Holdings Inc. (NYSE:LH)July 3, 2025 | marketbeat.comKerrii B. Anderson Sells 500 Shares of Labcorp Holdings Inc. (NYSE:LH) StockJuly 2, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $43.78 Million Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)July 2, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Grows Stake in Labcorp Holdings Inc. (NYSE:LH)July 2, 2025 | marketbeat.comLabcorp (NYSE:LH) Hits New 52-Week High - Time to Buy?July 1, 2025 | marketbeat.comKBC Group NV Grows Position in Labcorp Holdings Inc. (NYSE:LH)July 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeLDR, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$172.69 -1.28 (-0.74%) Closing price 03:59 PM EasternExtended Trading$172.67 -0.02 (-0.01%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$143.83 +1.02 (+0.71%) Closing price 03:59 PM EasternExtended Trading$143.82 -0.01 (0.00%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Landauer NYSE:LDRLandauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company's Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company's Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.Labcorp NYSE:LH$257.68 -0.19 (-0.07%) As of 03:59 PM EasternLabcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
